Stada expands in USA with product acquisitions

Germany's Stada Arzneimittel has acquired a generic product range with asales volume of $4 million for its US subsidiary. The drugs were bought from American Home Products' ESI Lederle unit and include 81 Abbreviated New Drug Application-approved products and 11 with pending ANDAs for various indications.

With this acquisition, Stada says it is on track to continue the planned expansion of its marketing and sales company in the USA, the largest market for generics in the world. The first step was the takeover of the operations of Moval Laboratories, which had sales of $26 million last year, on January 1. For 2002, Stada now anticipates US turnover of around 38 million euros ($33.9 million) and targets further expansion of its US business by means of additional product acquisitions.